Stephane Potvin

Summary

Country: Canada

Publications

  1. ncbi Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses
    Stephane Potvin
    Clinique Cormier Lafontaine, Montreal, Quebec, Canada
    Int Clin Psychopharmacol 18:121-32. 2003
  2. ncbi Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial
    Stephane Potvin
    Centre de Recherche Fernand Seguin, Hopital Louis H Lafontaine, Montreal, Canada
    Curr Med Res Opin 22:1277-85. 2006
  3. ncbi Neural correlates of the affect regulation model in schizophrenia patients with substance use history: a functional magnetic resonance imaging study
    Adham Mancini-Marie
    Department of Psychiatry, Fernand Seguin Research Center, Louis H Lafontaine Hospital, University of Montreal, Montreal, Quebec, Canada
    J Clin Psychiatry 67:342-50. 2006
  4. doi Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy
    Stephane Potvin
    Fernand Seguin Research Center, Louis H Lafontaine Hospital and Biomedical Sciences Program, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada
    J Psychopharmacol 22:262-9. 2008
  5. doi Working memory and depressive symptoms in patients with schizophrenia and substance use disorders
    Stephane Potvin
    Fernand Seguin Research Center, University of Montreal, Montreal, Canada
    Cogn Neuropsychiatry 13:357-66. 2008
  6. doi Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study
    Josiane Bourque
    Centre de Recherche Fernand Seguin, Montreal, QC, Canada
    Psychiatry Res 214:24-32. 2013
  7. doi Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia
    Simon Zhornitsky
    Faculty of Medicine, Department of Psychiatry, Fernand Seguin Research Centre, Universite de Montreal, Montreal, Canada
    Mov Disord 25:2188-94. 2010
  8. doi Predictors of community functioning in schizophrenia and substance use disorder patients
    Simon Zhornitsky
    Fernand Seguin Research Centre, Department of Psychiatry, Faculty of Medicine, Universite de Montreal, Montreal, QC, Canada
    Community Ment Health J 49:317-22. 2013
  9. doi Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis
    Simon Zhornitsky
    Department of Psychiatry, Faculty of Medicine, University of Montreal, Fernand Seguin Research Centre, Montreal, Quebec, Canada
    J Clin Psychopharmacol 30:417-24. 2010
  10. doi Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients
    Simon Zhornitsky
    Department of Psychiatry, Faculty of Medicine, University of Montreal, Montreal, Canada
    Psychiatry Res 200:237-41. 2012

Collaborators

Detail Information

Publications51

  1. ncbi Clozapine, quetiapine and olanzapine among addicted schizophrenic patients: towards testable hypotheses
    Stephane Potvin
    Clinique Cormier Lafontaine, Montreal, Quebec, Canada
    Int Clin Psychopharmacol 18:121-32. 2003
    ....
  2. ncbi Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial
    Stephane Potvin
    Centre de Recherche Fernand Seguin, Hopital Louis H Lafontaine, Montreal, Canada
    Curr Med Res Opin 22:1277-85. 2006
    ..Quetiapine shares crucial pharmacological properties with clozapine. Promising results have been described with quetiapine therapy in patients with psychosis and substance use disorder...
  3. ncbi Neural correlates of the affect regulation model in schizophrenia patients with substance use history: a functional magnetic resonance imaging study
    Adham Mancini-Marie
    Department of Psychiatry, Fernand Seguin Research Center, Louis H Lafontaine Hospital, University of Montreal, Montreal, Quebec, Canada
    J Clin Psychiatry 67:342-50. 2006
    ..We hypothesized that patients with a history of substance use would have increased cerebral activations in response to aversive stimuli when compared to abstinent patients...
  4. doi Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy
    Stephane Potvin
    Fernand Seguin Research Center, Louis H Lafontaine Hospital and Biomedical Sciences Program, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada
    J Psychopharmacol 22:262-9. 2008
    ..Lastly, baseline anandamide predicted endpoint SUD scores (alcohol/ cannabis). Anandamide is a potential target for medications aimed at relieving SUD in schizophrenia...
  5. doi Working memory and depressive symptoms in patients with schizophrenia and substance use disorders
    Stephane Potvin
    Fernand Seguin Research Center, University of Montreal, Montreal, Canada
    Cogn Neuropsychiatry 13:357-66. 2008
    ..Regarding cognition, the prevailing literature has produced mixed results. Some groups have reported greater cognitive impairments in dual diagnosis schizophrenia, while other groups have described the reverse...
  6. doi Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study
    Josiane Bourque
    Centre de Recherche Fernand Seguin, Montreal, QC, Canada
    Psychiatry Res 214:24-32. 2013
    ..Longitudinal studies will need to determine whether the relative preservation of emotional memory is primary or secondary to cannabis abuse in schizophrenia...
  7. doi Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia
    Simon Zhornitsky
    Faculty of Medicine, Department of Psychiatry, Fernand Seguin Research Centre, Universite de Montreal, Montreal, Canada
    Mov Disord 25:2188-94. 2010
    ..Our results suggest that PAS abuse is a contributor to EPS in individuals with and without schizophrenia...
  8. doi Predictors of community functioning in schizophrenia and substance use disorder patients
    Simon Zhornitsky
    Fernand Seguin Research Centre, Department of Psychiatry, Faculty of Medicine, Universite de Montreal, Montreal, QC, Canada
    Community Ment Health J 49:317-22. 2013
    ..Future studies will need to replicate the current findings, using prospective research designs...
  9. doi Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis
    Simon Zhornitsky
    Department of Psychiatry, Faculty of Medicine, University of Montreal, Fernand Seguin Research Centre, Montreal, Quebec, Canada
    J Clin Psychopharmacol 30:417-24. 2010
    ..They also suggest that these agents are not effective at treating stimulant dependence and may aggravate the condition in some cases...
  10. doi Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients
    Simon Zhornitsky
    Department of Psychiatry, Faculty of Medicine, University of Montreal, Montreal, Canada
    Psychiatry Res 200:237-41. 2012
    ....
  11. doi Pain inhibition is deficient in chronic widespread pain but normal in major depressive disorder
    Edith Normand
    Departement de Neurochirurgie, Faculte de Medecine, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
    J Clin Psychiatry 72:219-24. 2011
    ..This cross-sectional study measured experimentally induced pain perception and inhibition in patients with MDD and patients with fibromyalgia...
  12. ncbi Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia
    Stephane Potvin
    Fernand Seguin Research Center, Louis H Lafontaine Hospital, Montreal, Canada
    Am J Drug Alcohol Abuse 34:75-82. 2008
    ..Further studies are warranted to dissociate the causes and consequences of substance abuse in schizophrenia...
  13. doi Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial
    Elie Rizkallah
    University of Montreal, Fernand Seguin Research Center, Department of Psychiatry, Hochelaga, Montreal, Canada
    Expert Opin Pharmacother 11:2947-51. 2010
    ..The primary objective of the current open-label trial was to examine the effects of quetiapine on SUD outcomes in patients entering detoxification...
  14. ncbi Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis
    Stephane Potvin
    Fernand Seguin Research Center, University of Montreal, Montreal, Canada
    Schizophr Res 100:242-51. 2008
    ..It is concluded that previous mixed results obtained with cognitive evaluations of persons with Sz+SUD might reflect the heterogeneity of participants and that subgroups of patients might be defined on the basis of intermediate factors...
  15. doi Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine
    Simon Zhornitsky
    Centre de Recherche Fernand Seguin, Hôpital Louis H Lafontaine et Département de Psychiatrie, Universite de Montreal, Montreal, Quebec, Canada H1N 3V2
    Eur Neuropsychopharmacol 20:695-703. 2010
    ..Further research should investigate whether repeated treatment with quetiapine has the ability to reverse amphetamine withdrawal-induced anhedonia...
  16. ncbi Quetiapine: focus on emotional numbing in depersonalization disorder: an fMRI case report
    Adham Mancini-Marie
    Center de Recherche Fernand Seguin, Hôpital Louis Hippolyte Lafontaine, University of Montreal, 7331, rue Hochelaga, Montreal, Quebec, Canada H1N 3V2
    Eur Psychiatry 21:574-7. 2006
  17. doi Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profile
    Emmanuel Stip
    Department of Psychiatry, University of Montreal, Montreal, Quebec, Canada
    Clin Ther 33:1853-67. 2011
    ..Among atypical antipsychotics, ziprasidone exhibits a unique clinical profile. However, prescription rates for this medication remain among the lowest of all atypical antipsychotics...
  18. doi Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial
    Stephane Potvin
    Centre de Recherche Fernand Seguin, Department of Psychiatry, Faculty of Medicine, University of Montreal, Montreal, Canada
    J Clin Psychopharmacol 32:684-7. 2012
    ..2 mg) of quetiapine, we observed significant benefits of drug treatment on sleep, uncertain effects on FM and mood symptoms, but no effects on pain, in a small group of polymedicated FM patients. Quetiapine was generally well tolerated...
  19. doi Could the use of energy drinks induce manic or depressive relapse among abstinent substance use disorder patients with comorbid bipolar spectrum disorder?
    Elie Rizkallah
    Clinique Nouveau Départ, Montreal, Canada
    Bipolar Disord 13:578-80. 2011
    ..Clinical observations of three bipolar disorder patients with comorbid substance use disorder revealed an excessive consumption of energy drinks prior to manic or depressive relapse...
  20. ncbi Pain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitization
    Stephane Potvin
    Centre de Recherche Fernand Seguin, University of Montreal, Montreal, Canada
    J Psychiatr Res 42:1010-6. 2008
    ..Preliminary experimental studies have shown diminished pain sensitivity in schizophrenia patients. The objective of the study was to investigate the role of excitatory and inhibitory systems on pain perception in schizophrenia...
  21. doi Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravings
    Stephane Potvin
    Centre de recherche de l Institut universitaire en santé mentale de Montréal, Montreal, Canada Department of Psychiatry, University of Montreal, Montreal, Canada Electronic address
    Schizophr Res 173:30-6. 2016
    ..We hypothesized that cigarettes cues would elicit increased activations in brain regions involved in drug cravings in schizophrenia smokers relative to control smokers...
  22. doi Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis
    Valerie Tourjman
    Centre de recherche de l Institut universitaire en santé mentale de Montréal, Montreal, Canada Department of Psychiatry, Faculty of Medicine, University of Montreal, Montreal, Canada
    Schizophr Res 151:43-7. 2013
    ..Evidence-based medicine suggests that schizophrenia is associated with an inflammatory syndrome, but the extent to which this syndrome is normalized by antipsychotic treatment has yet to be determined...
  23. ncbi Processing of social emotion in patients with schizophrenia and substance use disorder: an fMRI study
    Stephane Potvin
    University of Montreal, Montreal, Quebec, Canada
    Soc Neurosci 2:106-16. 2007
    ..Our results suggest that socioemotional processing may be less impaired in dual diagnosis, which recruited brain regions seemingly involved in "social cognition." Further studies on the topic are warranted...
  24. doi Questioning the specificity of ASRS-v1.1 to accurately detect ADHD in substance abusing populations
    Jean Pierre Chiasson
    Clinique Nouveau Départ, Montreal, Canada
    J Atten Disord 16:661-3. 2012
    ..To assess the specificity of the Adult ADHD Self-Report Scale (ASRS-v1.1) in detecting ADHD among individuals with substance use disorders (SUDs)...
  25. doi Is the Mood Disorder Questionnaire an appropriate screening tool in detecting bipolar spectrum disorder among substance use populations?
    Jean Pierre Chiasson
    Clinique Nouveau Départ, Montreal, Quebec, Canada
    Am J Drug Alcohol Abuse 37:79-81. 2011
    ..Bipolar spectrum disorder (BSD) has been shown to be difficult to assess in general and is further complicated by the presence of substance use disorder (SUD)...
  26. ncbi The paradox of quetiapine in obsessive-compulsive disorder
    Constantin Tranulis
    Department of Psychiatry, Louis H Lafontaine Hospital, Montreal, Canada
    CNS Spectr 10:356-61. 2005
    ..The discussion emphasizes the prognostic implications of OCS in schizophrenia and available therapies for this comorbidity...
  27. ncbi Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis
    Amir Ali Sepehry
    Fernand Seguin Research Center, Louis H Lafontaine Hospital, Montreal, Quebec, Canada
    J Clin Psychiatry 68:604-10. 2007
    ..It has been proposed that selective serotonin reuptake inhibitor (SSRI) augmentation therapy in schizophrenia could provide a greater relief of these symptoms. Published studies, however promising, have produced conflicting results...
  28. doi Executive-affective connectivity in smokers viewing anti-smoking images: an fMRI study
    Laurence Dinh-Williams
    Centre de recherche de l Institut Universitaire en Santé Mentale de Montréal and Department of Psychiatry, University of Montreal, Montreal, Canada
    Psychiatry Res 224:262-8. 2014
    ..This mechanism may reduce the extent to which "feeling bad" brings about a change in behavior. ..
  29. pmc Is the deficit in pain inhibition in fibromyalgia influenced by sleep impairments?
    Emilie Paul-Savoie
    Department of Surgery, Faculty of Medicine and Health Sciences, Université de Sherbrooke Sherbrooke, Quebec, Canada
    Open Rheumatol J 6:296-302. 2012
    ..Future studies will need to replicate this finding, to determine whether impaired sleep is primary or secondary to deficient pain inhibition, and to characterize the neurobiological mechanisms underlying this association...
  30. doi Switching from conventional antipsychotics to ziprasidone: a randomized, open-label comparison of regimen strategies
    Emmanuel Stip
    Centre de Recherche Fernand Seguin, Hopital L H Lafontaine, Universite de Montreal, Montreal, Quebec, Canada
    Prog Neuropsychopharmacol Biol Psychiatry 34:997-1000. 2010
    ..However, these differences did not remain significant at endpoint, suggesting that there was no overall difference between the strategies...
  31. doi Quetiapine blocks cocaine-induced enhancement of brain stimulation reward
    Alexandra Gallo
    Centre de Recherche Fernand Seguin, Hôpital Louis H Lafontaine et Département de Psychiatrie, Universite de Montreal, Montreal, Quebec, Canada H1N 3V2
    Behav Brain Res 208:163-8. 2010
    ..Its actions on dopamine and non-dopamine neurotransmission are likely to account for its effectiveness at blocking the enhancement of reward by cocaine...
  32. doi Substance abuse is associated with increased extrapyramidal symptoms in schizophrenia: a meta-analysis
    Stephane Potvin
    Centre de Recherche Fernand Seguin, Department of Psychiatry, Faculty of Medicine, University of Montreal, Montreal, Canada
    Schizophr Res 113:181-8. 2009
    ..Clinical data have been gathered about the effects of PAS on EPS in schizophrenia, producing inconsistent results. This meta-analysis sought to determine whether PAS enhance EPS in schizophrenia patients...
  33. ncbi Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia
    Stephane Potvin
    Fernand Seguin Research Centre, University of Montreal, Montreal, Canada
    Aust N Z J Psychiatry 41:792-9. 2007
    ..These results have methodological implications for future studies of depressive symptoms in dual-diagnosis patients, and potential implications for the prevention and treatment of depressive symptoms in schizophrenia...
  34. doi Schizophrenia and serious violence: a clinical-profile analysis incorporating impulsivity and substance-use disorders
    Alexandre Dumais
    Philippe Pinel Institute of Montreal, Fernand Seguin Research Center, Department of Psychiatry of the University of Montreal, Montreal, Canada
    Schizophr Res 130:234-7. 2011
    ..This study is an exploration of the role of SUD and impulsivity in individuals with schizophrenia who are at higher risk of serious violence (SV)...
  35. doi Abnormal effective fronto-limbic connectivity during emotion processing in schizophrenia
    Stephane Potvin
    Department of Psychiatry, University of Montreal, Montreal, Canada Centre de recherche de l Institut universitaire en santé mentale de Montréal, Montreal, Canada Electronic address
    Prog Neuropsychopharmacol Biol Psychiatry 72:1-8. 2017
    ..However, the direction of the impaired fronto-limbic connections remains largely unknown. To clarify this issue, we performed an effective connectivity study on emotion processing in schizophrenia...
  36. doi Increased spinal pain sensitization in major depressive disorder: A pilot study
    Andràs Tikàsz
    Department of Psychiatry, Faculty of Medicine, University of Montreal, Montreal, Canada Centre de recherche de l Institut universitaire en santé mentale de Montréal, Montreal, Canada
    Psychiatry Res . 2016
    ..Together, these results suggest increased spinal pain sensitization in MDD, which might explain the high prevalence of painful somatic symptoms in these patients...
  37. doi Triggering Descending Pain Inhibition by Observing Ourselves or a Loved-One in Pain
    Véronique Gougeon
    Departement de Chirurgie, Service de Neurochirurgie, Équipe de recherche sur la douleur École de réadaptation, Faculte de Medecine et des Sciences de la Sante, Universite de Sherbrooke, Sherbrooke Département de psychiatrie, Faculte de Medecine, Universite de Montreal, Montreal, QC, Canada
    Clin J Pain 32:238-45. 2016
    ..This study, therefore, aimed to determine if the observation of ourselves or a loved-one in pain could activate descending pain inhibition without exposure to a noxious stimulation; which is otherwise required...
  38. doi Sex differences in effective fronto-limbic connectivity during negative emotion processing
    Ovidiu Lungu
    Department of Psychiatry, University of Montreal, Montreal, Canada Centre de recherche de l Institut universitaire de gériatrie de Montréal, Montreal, Canada Centre for Research in aging Donald Berman Maimonides Geriatric Centre, Montreal, Canada
    Psychoneuroendocrinology 62:180-8. 2015
    ..Here, we investigated sex-differences in fronto-limbic connectivity during negative emotion processing...
  39. doi Emotion processing in treatment-resistant schizophrenia patients treated with clozapine: An fMRI study
    Stephane Potvin
    Centre de recherche de l Institut universitaire en santé mentale de Montréal, Montreal, Canada Department of Psychiatry, University of Montreal, Montreal, Canada Electronic address
    Schizophr Res 168:377-80. 2015
    ..To examine the neural correlates of emotion processing in treatment-resistant patients with schizophrenia (SCZ-TR)...
  40. doi Cocaine and cognition: a systematic quantitative review
    Stephane Potvin
    From the Department of Psychiatry SP, KS, ER, Faculty of Medicine, Centre de recherche de l Institut universitaire en santé mentale de Montréal, University of Montreal, Montreal, Quebec, Canada Clinique du Nouveau Départ KS, ER, Montreal, Quebec, Canada and Department of Psychiatry JP, Faculty of Medicine, Institut universitaire en santé mentale de Montréal, University of Montreal, Montreal, Quebec, Canada
    J Addict Med 8:368-76. 2014
    ..Here, we performed a meta-analysis to determine the cognitive domains impaired in cocaine abuse/dependence and the duration of abstinence necessary to achieve cognitive recovery...
  41. ncbi Analgesic and antihyperalgesic effects of nabilone on experimental heat pain
    William John Redmond
    Universite de Sherbrooke, Faculte de Medecine, Sherbrooke, Quebec, Canada
    Curr Med Res Opin 24:1017-24. 2008
    ..In this study, we explored the analgesic and antihyperalgesic properties of a synthetic cannabinoid (nabilone) on experimental heat pain in men and women, as well as its effects on descending pain inhibitory systems...
  42. pmc Markedly Reduced Thermal Pain Perception in a Schizoaffective Patient with Tardive Dyskinesia
    Stephane Potvin
    Centre de recherche de l Institut universitaire en santé mentale de Montréal, 7331 Hochelaga, Montreal, QC, Canada H1N 3V2 Department of Psychiatry, Faculty of Medicine, University of Montreal, C P 6128, Succursale Centre Ville, Montreal, QC, Canada H3C 3J7
    Case Rep Psychiatry 2016:8702483. 2016
    ..Future studies in the field will need to pay attention to drug-induced extrapyramidal symptoms. ..
  43. pmc Emotionally Neutral Stimuli Are Not Neutral in Schizophrenia: A Mini Review of Functional Neuroimaging Studies
    Stephane Potvin
    Centre de recherche de l Institut universitaire en santé mentale de Montréal, Montreal, QC, Canada Department of Psychiatry, Faculty of Medicine, University of Montreal, Montreal, QC, Canada
    Front Psychiatry 7:115. 2016
    ..In the future, the effects of antipsychotics on this aberrant brain reactivity will need to be determined, as well as the potential implication of sex/gender. ..
  44. doi Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders
    Stephane Potvin
    Centre de recherche de l, Institut universitaire en santé mentale de Montréal, 7331 Hochelaga, Montreal, QC, H1N 3V2, Canada
    Eur Arch Psychiatry Clin Neurosci 265:147-54. 2015
    ..Our results will need to be replicated in longitudinal studies involving larger samples of patients. ..
  45. pmc Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis
    Stephane Potvin
    Researcher, Centre de recherche de l Institut universitaire en santé mentale de Montréal, Montreal, Quebec Associate Research Professor, Department of Psychiatry, University of Montreal, Montreal, Quebec
    Can J Psychiatry 60:S26-34. 2015
    ..Thus far, studies on leptin changes during AP treatment have produced inconsistent results, prompting our group to perform a meta-analysis...
  46. doi Where there's smoke, there's fire: the brain reactivity of chronic smokers when exposed to the negative value of smoking
    Laurence Dinh-Williams
    Centre de Recherche Fernand Seguin, Institut Universitaire de Santé Mentale de Montréal, Montreal, Canada Department of Psychiatry, Faculty of Medicine, University of Montreal, Montreal, Canada
    Prog Neuropsychopharmacol Biol Psychiatry 50:66-73. 2014
    ..Studies have shown that smokers are roused by appetitive smoking-related stimuli, and their consumption tends to be unaffected by the negative value of smoking...
  47. ncbi Orbitofrontal dysfunction in a monozygotic twin discordant for postpartum affective psychosis: a functional magnetic resonance imaging study
    Cherine Fahim
    Department of Psychiatry, Centre de Recherche Fernand Seguin, Hopital Louis H Lafontaine, Montreal, QC, Canada
    Bipolar Disord 9:541-5. 2007
    ..At the end of the third trimester, there is a sudden drop in estrogen, which exerts prominent effects on the serotonergic system in the orbitofrontal cortex (OFC)...
  48. ncbi Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review
    Stephane Potvin
    Department of Psychiatry, Faculty of Medicine, University of Montreal, Fernand Seguin Research Center, Louis H Lafontaine Hospital, Montreal, Quebec, Canada
    Biol Psychiatry 63:801-8. 2008
    ..However, data published so far have been inconsistent. The primary objective of the present meta-analysis was to verify whether the cytokine imbalance hypothesis of schizophrenia is substantiated by evidence...
  49. ncbi Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB
    Marie Noëlle Levaux
    Centre de Recherche Fernand Seguin, Hopital Louis H Lafontaine, Montreal, Quebec, Canada
    Eur Psychiatry 22:104-15. 2007
    ..A clear approach concerning the usage of CANTAB for the appraisal of neurocognitive dysfunction in schizophrenia is currently lacking...
  50. ncbi Cannabis and psychosis: what is the link?
    Mohamed Ben Amar
    Faculties of Continuing Education and Graduate Studies, University of Montreal, Quebec, Canada
    J Psychoactive Drugs 39:131-42. 2007
    ..This conclusion should be mitigated by uncertainty arising from cannabis use assessment, psychosis measurement, reverse causality and control of residual confounding...
  51. doi Pain facilitation and pain inhibition during conditioned pain modulation in fibromyalgia and in healthy controls
    Stephane Potvin
    aCentre de recherche de l Institut Universitaire en Santé Mentale de Montréal, Montreal, Quebec, Canada bDepartment of Psychiatry, Faculty of Medicine, Universite de Montreal, Montreal, Quebec, Canada cCentre de recherche du Centre Hospitalier de l Université de Sherbrooke, Sherbrooke, Quebec, Canada dDepartment of Surgery, Faculty of Medicine and Health Sciences, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
    Pain 157:1704-10. 2016
    ....